Home |Research|Staff|Publications

Publications

Dr. Cathrin Rohleder

Bien CG, Rohleder C, Mueller JK, Bien CI, Koethe D, Leweke FM. Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers. Front Psychiatry. 2021 12:654602.
Leweke FM, Rohleder C, Gerth CW, Hellmich M, Pukrop R, Koethe D. Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial. Front Pharmacol. 2021 12:614811.
Meinhardt M, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021 7(47):eabh2399.
Moldavski A, Wenz H, Lange BE, Rohleder C, Leweke FM. Case Report: Severe Adolescent Major Depressive Syndrome Turns Out to Be an Unusual Case of Anti-NMDA Receptor Encephalitis. Front Psychiatry. 2021 12:679996.
Nichles A, Zmicerevska N, Song YJC, Wilson C, McHugh C, Hamilton B, Crouse J, Rohleder C, Carpenter JS, Ho N, Hermens DF, Wray N, Scott J, Merikangas KR, Leweke FM, Koethe D, Iorfino F, Naismith SL, Guastella AJ, Scott EM, Hickie IB. Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention service. BMJ Open. 2021 11(6):e044731.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de